Article
Molecular Basis of Resistance to First-Line Drugs of Mycobacterium tuberculosis/canettii Strains in Greece.
Microbial drug resistance (Larchmont, N.Y.) - 1 Oct 2021
Florou Zoi, Mavroidi Aggeliki, Vatidis George, Daniil Zoi, Gourgoulianis Konstantinos, Petinaki Efi
Abstract excerpt
The aim of this study was to determine the rate and the mutations of genes involved to the first-line antituberculous drugs' resistance of M. tuberculosis/canettii isolated in Central Greece from 2010 to 2019. During the study period, the rate of resistance to isoniazid, rifampicin, ethambutol, and pyrazinamide was 5.4%, 0.4%, 1.1%, and 1.1%, respectively. All phenotypically resistant isolates (14 to isoniazid, 3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
